Batch Notification View

Batch Notification Number BN-OL-2022-09-27-4942
FDA Registered Product/Generic Name Co-amoxiclav
Brand Name NATRAVOX
Dosage Strength 250 mg/ 62.5 mg/ 5 mL
Dosage Form Powder for Suspension
Registration Number DR-XY34778
Batch Number 22NS215
Lot Number N/A
Product Expiration Date 1 March 2024
Issuance Date 28 September 2022